Myricitrin, a botanical flavonol glycoside, could be a useful ingredient of functional foods, cosmetics, and medicines because of its high anti-oxidative activity. However, due to its insolubility in water, it has a limited range of use. To improve this solubility, we glycosylated myricitrin by an enzymatic transglycosylate reaction. Myricitrin was galactosylated by -galactosidase from Bacillus circulans using lactose as a sugar donor. The reaction product was 480 times more soluble than myricitrin. Four myricitrin galactosides were isolated from the reaction products by column chromatography, and their molecular structures were identified by using
Polyphenols are secondary metabolites with antioxidative activity. [1] [2] [3] [4] Myricitrin, a polyphenol, is a flavonol rhamnoside contained in such plants as bayberry. [5] [6] [7] Myricitrin contains myricetin, which is known to have strong anti-oxidative activity, as an aglycone part. 8, 9) Myricitrin is also a powerful anti-oxidant based on its mechanisms for metal-ion chelation, free-radical scavenging, and ultraviolet filtration. 10) Moreover, myricitrin has recently been reported to inhibit the oxidation of low-density lipoprotein. 11) Myricitrin could be a useful anti-oxidative ingredient, but its range of use has been limited because of its low water solubility. Meanwhile, transglycosylation by enzymes from various bacteria has been used to improve such the physiochemical properties as the solubility in water, taste and oxidative stability of various compounds. [12] [13] [14] [15] [16] [17] [18] [19] -Galactosidase is one of those enzymes, and it is known to have high transglycosylation activity for practical use. 20) However, to our knowledge, there has been little study on improving the water solubility by using -galactosidase.
In this study, we used -galactosidase from Bacillus circulans to synthesize new highly water soluble myricitrin derivatives. We succeeded in the transglycosylation of myricitrin by using lactose as the sugar donor. The four major transglycosylation products of myricitrin were isolated and their structures were determined. Additionally, the water solubility, lipid peroxidation-preventing activity, and radical-scavenging activity of these four products were examined.
Materials and Methods
Materials. Myricitrin was purchased from Funakoshi Co. (Tokyo, Japan), and the -Galactosidase preparation, Biolacta FN5, from Bacillus circulans was purchased from Daiwa Kasei Co. (Shiga, Japan). All other reagents used were of analytical grade from commercial sources.
Assay of -galactosidase activity. The activity ofgalactosidase was measured by referring to Miller's method. 21) A phosphate buffer (0.05 M, pH 7.0) containing 2 mM o-nitrophenyl--D-galactoside (ONPG) and an appropriate amount of the enzyme (0.2 ml in total), was incubated at 40 C for 15 min. After stopping the reaction by adding 1.0 M Na 2 CO 3 (1 ml), o-nitrophenol was measured at 420 nm. One unit is defined as the amount of enzyme that produced 1 mmole of o-nitrophenol from ONPG per min.
High-performance liquid chromatography (HPLC).
HPLC was run with a Jasco 887-PU pump and a Jasco 875-UV detector under the following conditions: column, YMC-Pack ODS-AQ (4:6 Â 250 mm); solvent, 15% CH 3 CN in 0.1% H 3 PO 4 ; flow rate, 1.0 ml/min; column temperature, ambient; detection wavelength, 351 nm.
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NMR.
1 H-and 13 C-NMR spectra were recorded at 600 MHz with a Jeol JMTC-600/54/SS NMR spectrometer. A sample was dissolved in DMSO-d 6 or methanol-d 4 .
1 H-1 H COSY, 1 H-13 C HMQC and 1 H-13 C HMBC experiments were performed by using a pulse sequence supplied by Jeol.
Solubility determination. Excess myricitrin or myricitrin galactoside was suspended in 1 ml of ionexchanged water in an Eppendorf tube at room temperature. After sonicating at room temperature for 1 h, the sample was centrifuged at 12;000 Â g for 15 minutes. The concentration of the compounds in the supernatant, which is defined as the solubility, was estimated by the HPLC absolute calibration method for both myricitrin and myricitrin galactoside. In the present experiment, however, the concentration of the mixture of reaction products (myricitrin and myricitrin galactoside) was estimated by the absolute calibration method, in which the sum of the total peaks areas of myricitrin and myricitrin galactoside on the chromatogram of the sample was compared with the standard myricitrin peak area.
Assay for the inhibition of lipid peroxidation. Ten ml of commercially available milk was poured into a Petri dish, and myricitrin or myricitrin galactoside was added at 6:3 Â 10 À2 mM. The solution was then irradiated with fluorescent light in an environment-controlled chamber for 3 hours at 10 C. After irradiation, the lipid peroxide concentration was estimated with a Lipid Hydroperoxide (LPO) Assay Kit (Cayman Chemical Company), based on measuring the oxidation of ferrous to ferric ions and subsequent complexation of the latter by thiocyanate. 22) The results were analyzed by Student's t test, P-values less than 0.05 being considered statistically significant.
Assay for the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity. The free radical-scavenging activity of myricitrin and each myricitrin galactoside was measured in terms of the hydrogen donating or radical-scavenging ability for the DPPH radical. 23) A DPPH solution in methanol at 0.1 mM was prepared, and 1.0 ml of this solution was added to 1.0 ml of a sample solution in methanol at different concentrations (0.3-6.0 mM). After 30 min at 37 C, the absorbance was measured at 517 nm. The lower the absorbance of the reaction mixture, the higher was the free radicalscavenging activity. The capability for scavenging the DPPH radical was calculated by the following equation:
where A cont is the absorbance of the reaction mixture without the sample and A test is the absorbance in the presence of the sample.
Results
Transgalactosylation of myricitrin by -galactosidase One g of myricitrin was dispersed in 50 ml of water at 50 C, and dissolved by dropping 1 M sodium hydroxide solution to pH 9.0. After the solution had been adjusted to pH 7.5 by dropping properly diluted sulfuric acid solution, 10 g of lactose was added and dissolved by stirring. Subsequently, 0.8 g of the -galactosidase preparation, Biolacta FN5 (5500 unit/g), was added. The solution containing lactose as a galactosyl residue donor and myricitrin as an acceptor was incubated while stirring at 50 C for 20 hours. After this incubation, the solution was adjusted to pH 3.0 by dropping properly diluted sulfuric acid solution to terminate the enzymatic reaction. An HPLC analysis of the solution showed three peaks (GA1, GA2 and GA3) other than myricitrin on the high-polarity side (Fig. 1) . Furthermore, an LC/MS analysis showed ionized peaks at m=z 626.
which respectively correspond to the calculated molecular masses of the protonated ion adducts of the monogalactoside, digalactoside and trigalactoside of myricitrin ( Table 1 ). The ratio of the total peak area of these galactoside components to that of myricitrin was 47.5%, with GA1, GA2 and GA3 respectively constituting 34.1%, 11.3% and 2.1%. GA2 was separated into GA2-a and GA2-b by HPLC with the Fluofix column in the ratio of 60:40.
Isolation of the enzymatically synthesized compounds
After filtering the reacted solution and removing the insoluble material, the filtrate was subjected to opencolumn chromatography on Sepabeads SP207 (Mitsubishi Chemical Corporation), eluting stepwise with distilled water and 60% ethanol and 80% ethanol. The 60%-ethanol fraction was evaporated to dryness and designated as EtFr. 60. EtFr. 60 dissolved in methanol was subjected to Sephadex LH-20 column chromatography, using 50% methanol as the eluent. The fractions were monitored by HPLC. Each fraction was grouped into three subfractions, these being designated as the GA1, GA2, and GA3 groups. The three subfractions were each evaporated and dissolved in a preparative HPLC mobile phase, before being subsequently separated into four components, GA1, GA2-a, GA2-b, and GA3 by preparative HPLC. Each component solution was evaporated and used for further analysis. The respective yields of components GA1, GA2-a, GA2-b, and GA3 were 295, 72, 35, and 20 mg.
Identification of the enzymatically synthesized compounds
In order to analyze the saccharide composition of with each enzymatically synthesized compound, it was hydrolyzed with -galactosidase and analyzed by HPLC. Only galactose was detected in the supernatant, and not rhamnose and glucose, with the RI detector, and only myricitrin was detected with the UV detector. Only myricitrin was detected in the precipitate of each compound. These results confirmed that GA1, GA2-a, GA2-b, and GA3 were transgalactosylated myricitrin, and not glucosides. The detailed molecular structures of the enzymatically synthesized compounds were identified by NMR (Fig. 2) . Tables 2 and 3 show the 1 H-NMR and 13 C NMR data, and correlations in the HMBC spectrum. The signals were assigned by using 1 H-1 H COSY, 1 H-13 C HMQC, and 1 H-13 C HMBC, and comparing with the chemical shifts in the reference data. [24] [25] [26] Furthermore, the configurations of anomeric carbons were defined from their coupling constants. In assigning the galactooligosaccharide moiety, the linkage site of the rhamnosyl residue with the galactosyl residue was first fixed by considering factors such as shifting of the chemical shifts in the 1 H-NMR and 13 C-NMR spectra. Continuously, the galactosyl anomeric carbon and proton with a rhamnosyl residue were then fixed by HMBC spectra. Starting from the anomeric carbon and proton, each signal was assigned by considering such factors as the 1 H-1 H COSY, 1 H-13 C HMQC, and 1 H-13 C HMBC spectra. It was comparatively easy to assign the C6 000 , C6 0000 , and C6 00000 carbons, because the chemical shifts were presented at a higher magnetic field than the other sugar carbons, so these carbons were also used as starting points in assignment.
The galactosylated position in GA1 was unambiguously determined from the correlation between galactosyl anomeric proton H-1 000 ( 4.15) and rhamnosyl C-2
00
( 81.7) in the HMBC spectrum. In addition, the configuration of the linkage was defined as from the H-1 000 coupling constant (J ¼ 7:7 Hz). GA1 was therefore identified to be myricetin
The galactosylated position in GA2-a was determined from the correlations in the HMBC spectrum between galactosyl anomeric proton H-1 000 ( 4.28) and rhamnosyl C-2 00 ( 81.7) and between galactosyl anomeric proton H-1 0000 ( 4.44) and galactosyl C-4 000 ( 77.6). In addition, the configurations of the linkages were respectively defined as from the H-1 000 coupling constant (J ¼ 6:8 Hz) and from the H-1 0000 coupling constant (J ¼ 8:3 Hz). GA2-a was therefore identified to be myricetin 3-
The glycosidation position in GA2-b was unambiguously determined from the correlations in the HMBC spectrum between galactosyl anomeric proton H-1 000 ( 4.37) and rhamnosyl C-2 00 ( 81.4) and between galactosyl anomeric proton H-1 0000 ( 4.49) and galactosyl C-3 000 ( 83.1). In addition, the configurations of the linkages were respectively defined as from the H-1 000 coupling constant (J ¼ 8:2 Hz) and from the H-1 0000 coupling constant (J ¼ 7:6 Hz). GA2-a was therefore identified to be myricetin
The galactosylation position in GA3 was unambiguously determined from the correlation in the HMBC spectrum between galactosyl anomeric proton H-1 000 ( 4.28) and rhamnosyl C-2 00 ( 81.5), between galactosyl anomeric proton H-1 0000 ( 4.45) and galactosyl C-4 000 ( 77.7), and between galactosyl anomeric proton H-1 00000 ( 4.41) and galactosyl C-4 0000 ( 78.1). In addition, the configurations of the linkages were respectively defined as from the H-1 000 coupling constant (J ¼ 6:8 Hz), from the H-1 0000 coupling constant (J ¼ 6:8 Hz), and from the H-1 00000 coupling constant (J ¼ 8:3 Hz). GA3 was therefore identified to be myricetin
Water solubility of the galactosylated compounds The water solubility of each myricitrin galactoside was evaluated and compared with that of myricitrin 1 H-and 13 C-NMR Data for GA1, GA2-a, and GA2-b ( ppm, J Hz) (GA1, in DMSO-d 6 ; GA2-a and GA2-b, in methanol-d 4 )
( Table 4) . Although EtFr. 60 contained about 50% of myricitrin, the water solubility was increased to 1:2 Â 10 5 mM, which is 480-fold that of myricitrin. The water solubility of GA1, GA2-a, GA2-b and GA3 was too high to measure, and was therefore considered to be higher than 1 Â 10 6 mM, this being more than 3:9 Â 10 3 fold higher than that of myricitrin.
Lipid peroxidation-preventing effect of the galactosides
To examine the difference in the anti-oxidation ability among the myricitrin galacosides with different structures, we examined the lipid peroxidation-preventing effect of myricitrin and each myricitrin galactoside. Figure 3 shows the amount of lipid peroxide generated by irradiating for 3 hours. Each myricitirin galactoside suppressed about 60% of the generation of lipid peroxide in milk, showing an anti-oxidation effect almost equal to that of myricitrin. It is therefore thought that the anti-oxidative ability of myricitrin had hardly changed by galactosylation.
DPPH radical scavenging activity of the galactosyl compounds Figure 4 shows the DPPH-radical scavenging activity of myricitrin and each myricitrin galactoside with different structures. Each myricitrin galactoside showed dose-dependent activity similar to that of myricitrin. The radical-scavenging activity of myricitrin had therefore hardly been changed by galactosylation.
Discussion
Many studies regarding transglycosylation have reported techniques for improving water solubility. 12, 14, 17, 19) Although the transglycosylation of rutin and hesperidin for practical use has been reported, most of the reports on glucosylation have used cyclodextrin glucanotransferase (CGTase). On the other hand, many studies have been reported on transglycosylation using galactosidase. 20) There have been recent reports concerning regioselectivity and substrate specificity in the transglycosylation with galactosidases from a variety of bacterial origins. 27, 28) Moreover, synthetic studies on unique compounds such as poly-N-acetyllactosamines and nucleotide-activated oligosaccharides have been carried out. 28, 29) However, there are few reports on the effect of glycosylation on the water solubility of insoluble components, though galactosylation to the thiol group in order to improve taste have been reported. 30) Moreover, there are few reports on galactosylation to the rhamnose residue by using -galactosidase. This present report is the first to identifiy the uniting part of the galactosyl rhamnoside of enzymatically synthesized components. The four galactosyl myricitrins identified in this report are all novel components. Although there are some reports on natural components with galactosyl rhamnose residue, these components are not myricetin with a galactosyl rhamnose residue. [31] [32] [33] Galactosylation to myricitrin was different from transglycosylation by CGTase like glucosylhesperidin and glucosylrutin, and didn't form myricitrin with a long oligosaccharide chain. 12, 17) It is thought that there is a difference in the balance of transglycosylation and hydrolysis between CGTase and -galactosidase. More- over, although two kinds of GA2 were generated by galactosylation, the galactosylated product of GA2-a and not GA2-b was generated as a structure of GA3. It is suggested that there is a stereostructural reason for this. It is known that glucosyl hesperidin prevents hesperidin crystal formation in a liquid mixture of each element. 34) We had a similar result, the crystallization of myricitrin being prevented in the EtFr. 60 solution. We therefore think that myricitrin galactosides have the ability to prevent the crystallization of myricitrin by a mechanism similar to that of glucosyl hesperidin.
Each myricitrin galactoside had anti-oxidative activity similar to that of myricitrin. This means that the activity was not due to galactosylation of the myricetin skeleton. The water solubility of myricitrin was improved by galactosylation without lowering the antioxidative activity, extending the possibility of its use in functional foods, medicines and cosmetics. It is already known that a galactooligosaccharide has prebiotics activities like controlling intestinal functions by improvement fecal constitution and suppressing bone loss by promoting intestinal absorption of calcium. [35] [36] [37] [38] GA2-a, GA2-b and GA3 have potential application to prebiotics because those constituents possess the characteristics of a galactooligosaccharide. Amount of generation of lipid peroxide (µM) * * * * * * * * * * Fig. 3 . Lipid Peroxidation-Preventing Activity of the Myricitrin Galactosides. Control represents the non-irradiated sample that was shaded by aluminum foil. Blank represents the irradiated sample without myricitrin (or galactosides) added. Lipid peroxide is expressed as the 13-HpODE (13-hydroperoxyoctadecadienoic acid) equivalent. Each result is presented as the mean AE SD of 5 tests.
ÃÃ p < 0:01, significantly different when compared with the blank values.
